Published online 1 July 2005
Article |
Characterization of a novel transcriptionally active domain in the transforming growth factor ß-regulated Smad3 protein
1Department of Basic Sciences, University of Crete Medical School Heraklion 71003, Greece 2Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas Heraklion 71003, Greece
*To whom correspondence should be addressed. Tel: +30 2810 394549; Fax: +30 2810 394530; Email: kardasis{at}imbb.forth.gr
Revised May 20, 2005. Accepted June 12, 2005.
Transforming growth factor ß (TGFß) regulates transcriptional responses via activation of cytoplasmic effector proteins termed Smads. Following their phosphorylation by the type I TGFß receptor, Smads form oligomers and translocate to the nucleus where they activate the transcription of TGFß target genes in cooperation with nuclear cofactors and coactivators. In the present study, we have undertaken a deletion analysis of human Smad3 protein in order to characterize domains that are essential for transcriptional activation in mammalian cells. With this analysis, we showed that Smad3 contains two domains with transcriptional activation function: the MH2 domain and a second middle domain that includes the linker region and the first two ß strands of the MH2 domain. Using a proteinprotein interaction assay based on biotinylation in vivo, we were able to show that a Smad3 protein bearing an internal deletion in the middle transactivation domain is characterized by normal oligomerization and receptor activation properties. However, this mutant has reduced transactivation capacity on synthetic or natural promoters and is unable to interact physically and functionally with the histone acetyltransferase p/CAF. The loss of interaction with p/CAF or other coactivators could account, at least in part, for the reduced transactivation capacity of this Smad3 mutant. Our data support an essential role of the previously uncharacterized middle region of Smad3 for nuclear functions, such as transcriptional activation and interaction with coactivators.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Millet, M. Yamashita, M. Heller, L.-R. Yu, T. D. Veenstra, and Y. E. Zhang A Negative Feedback Control of Transforming Growth Factor-{beta} Signaling by Glycogen Synthase Kinase 3-mediated Smad3 Linker Phosphorylation at Ser-204 J. Biol. Chem., July 24, 2009; 284(30): 19808 - 19816. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, I. Matsuura, D. He, and F. Liu Transforming Growth Factor-{beta}-inducible Phosphorylation of Smad3 J. Biol. Chem., April 10, 2009; 284(15): 9663 - 9673. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Minoo, L. Hu, N. Zhu, Z. Borok, S. Bellusci, J. Groffen, D. Kardassis, and C. Li SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains Nucleic Acids Res., January 17, 2008; 36(1): 179 - 188. [Abstract] [Full Text] [PDF] |
||||

